1 Study Coverage 1.1 Hereditary Angioedema Drug Product Introduction 1.2 Market Segments 1.3 Key Hereditary Angioedema Drug Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Type 1.4.2 C1 Esterase Inhibitor 1.4.3 Kallikrein Inhibitor 1.4.4 Selective Bradykinin B2 Receptor Antagonist 1.5 Market by Application 1.5.1 Global Hereditary Angioedema Drug Market Size Growth Rate by Application 1.5.2 Retail Pharmacies 1.5.3 Hospital Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Hereditary Angioedema Drug Market Size, Estimates and Forecasts 2.1.1 Global Hereditary Angioedema Drug Revenue 2015-2026 2.1.2 Global Hereditary Angioedema Drug Sales 2015-2026 2.2 Global Hereditary Angioedema Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Hereditary Angioedema Drug Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Hereditary Angioedema Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Hereditary Angioedema Drug Competitor Landscape by Players 3.1 Hereditary Angioedema Drug Sales by Manufacturers 3.1.1 Hereditary Angioedema Drug Sales by Manufacturers (2015-2020) 3.1.2 Hereditary Angioedema Drug Sales Market Share by Manufacturers (2015-2020) 3.2 Hereditary Angioedema Drug Revenue by Manufacturers 3.2.1 Hereditary Angioedema Drug Revenue by Manufacturers (2015-2020) 3.2.2 Hereditary Angioedema Drug Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Hereditary Angioedema Drug Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Hereditary Angioedema Drug Revenue in 2019 3.2.5 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Hereditary Angioedema Drug Price by Manufacturers 3.4 Hereditary Angioedema Drug Manufacturing Base Distribution, Product Types 3.4.1 Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Hereditary Angioedema Drug Product Type 3.4.3 Date of International Manufacturers Enter into Hereditary Angioedema Drug Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Hereditary Angioedema Drug Market Size by Type (2015-2020) 4.1.1 Global Hereditary Angioedema Drug Sales by Type (2015-2020) 4.1.2 Global Hereditary Angioedema Drug Revenue by Type (2015-2020) 4.1.3 Hereditary Angioedema Drug Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Hereditary Angioedema Drug Market Size Forecast by Type (2021-2026) 4.2.1 Global Hereditary Angioedema Drug Sales Forecast by Type (2021-2026) 4.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Type (2021-2026) 4.2.3 Hereditary Angioedema Drug Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Hereditary Angioedema Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Hereditary Angioedema Drug Market Size by Application (2015-2020) 5.1.1 Global Hereditary Angioedema Drug Sales by Application (2015-2020) 5.1.2 Global Hereditary Angioedema Drug Revenue by Application (2015-2020) 5.1.3 Hereditary Angioedema Drug Price by Application (2015-2020) 5.2 Hereditary Angioedema Drug Market Size Forecast by Application (2021-2026) 5.2.1 Global Hereditary Angioedema Drug Sales Forecast by Application (2021-2026) 5.2.2 Global Hereditary Angioedema Drug Revenue Forecast by Application (2021-2026) 5.2.3 Global Hereditary Angioedema Drug Price Forecast by Application (2021-2026) 6 North America 6.1 North America Hereditary Angioedema Drug by Country 6.1.1 North America Hereditary Angioedema Drug Sales by Country 6.1.2 North America Hereditary Angioedema Drug Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Hereditary Angioedema Drug Market Facts & Figures by Type 6.3 North America Hereditary Angioedema Drug Market Facts & Figures by Application 7 Europe 7.1 Europe Hereditary Angioedema Drug by Country 7.1.1 Europe Hereditary Angioedema Drug Sales by Country 7.1.2 Europe Hereditary Angioedema Drug Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Hereditary Angioedema Drug Market Facts & Figures by Type 7.3 Europe Hereditary Angioedema Drug Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Hereditary Angioedema Drug by Region 8.1.1 Asia Pacific Hereditary Angioedema Drug Sales by Region 8.1.2 Asia Pacific Hereditary Angioedema Drug Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Type 8.3 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Application 9 Latin America 9.1 Latin America Hereditary Angioedema Drug by Country 9.1.1 Latin America Hereditary Angioedema Drug Sales by Country 9.1.2 Latin America Hereditary Angioedema Drug Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Hereditary Angioedema Drug Market Facts & Figures by Type 9.3 Central & South America Hereditary Angioedema Drug Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Hereditary Angioedema Drug by Country 10.1.1 Middle East and Africa Hereditary Angioedema Drug Sales by Country 10.1.2 Middle East and Africa Hereditary Angioedema Drug Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Type 10.3 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Application 11 Company Profiles 11.1 Pharming Group NV 11.1.1 Pharming Group NV Corporation Information 11.1.2 Pharming Group NV Description and Business Overview 11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered 11.1.5 Pharming Group NV Related Developments 11.2 Takeda 11.2.1 Takeda Corporation Information 11.2.2 Takeda Description and Business Overview 11.2.3 Takeda Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Takeda Hereditary Angioedema Drug Products Offered 11.2.5 Takeda Related Developments 11.3 CSL Limited 11.3.1 CSL Limited Corporation Information 11.3.2 CSL Limited Description and Business Overview 11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020) 11.3.4 CSL Limited Hereditary Angioedema Drug Products Offered 11.3.5 CSL Limited Related Developments 11.4 IBio Inc. 11.4.1 IBio Inc. Corporation Information 11.4.2 IBio Inc. Description and Business Overview 11.4.3 IBio Inc. Sales, Revenue and Gross Margin (2015-2020) 11.4.4 IBio Inc. Hereditary Angioedema Drug Products Offered 11.4.5 IBio Inc. Related Developments 11.5 BioCryst Pharmaceuticals, Inc. 11.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information 11.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview 11.5.3 BioCryst Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020) 11.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered 11.5.5 BioCryst Pharmaceuticals, Inc. Related Developments 11.6 Ionis Pharmaceuticals, Inc. 11.6.1 Ionis Pharmaceuticals, Inc. Corporation Information 11.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview 11.6.3 Ionis Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Products Offered 11.6.5 Ionis Pharmaceuticals, Inc. Related Developments 11.1 Pharming Group NV 11.1.1 Pharming Group NV Corporation Information 11.1.2 Pharming Group NV Description and Business Overview 11.1.3 Pharming Group NV Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Pharming Group NV Hereditary Angioedema Drug Products Offered 11.1.5 Pharming Group NV Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Hereditary Angioedema Drug Market Estimates and Projections by Region 12.1.1 Global Hereditary Angioedema Drug Sales Forecast by Regions 2021-2026 12.1.2 Global Hereditary Angioedema Drug Revenue Forecast by Regions 2021-2026 12.2 North America Hereditary Angioedema Drug Market Size Forecast (2021-2026) 12.2.1 North America: Hereditary Angioedema Drug Sales Forecast (2021-2026) 12.2.2 North America: Hereditary Angioedema Drug Revenue Forecast (2021-2026) 12.2.3 North America: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026) 12.3 Europe Hereditary Angioedema Drug Market Size Forecast (2021-2026) 12.3.1 Europe: Hereditary Angioedema Drug Sales Forecast (2021-2026) 12.3.2 Europe: Hereditary Angioedema Drug Revenue Forecast (2021-2026) 12.3.3 Europe: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Hereditary Angioedema Drug Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Hereditary Angioedema Drug Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Hereditary Angioedema Drug Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Hereditary Angioedema Drug Market Size Forecast by Region (2021-2026) 12.5 Latin America Hereditary Angioedema Drug Market Size Forecast (2021-2026) 12.5.1 Latin America: Hereditary Angioedema Drug Sales Forecast (2021-2026) 12.5.2 Latin America: Hereditary Angioedema Drug Revenue Forecast (2021-2026) 12.5.3 Latin America: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Hereditary Angioedema Drug Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Hereditary Angioedema Drug Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Hereditary Angioedema Drug Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Hereditary Angioedema Drug Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Hereditary Angioedema Drug Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Hereditary Angioedema Drug Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Hereditary Angioedema Drug Market Segments Table 2. Ranking of Global Top Hereditary Angioedema Drug Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Hereditary Angioedema Drug Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of C1 Esterase Inhibitor Table 5. Major Manufacturers of Kallikrein Inhibitor Table 6. Major Manufacturers of Selective Bradykinin B2 Receptor Antagonist Table 7. Global Hereditary Angioedema Drug Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global Hereditary Angioedema Drug Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global Hereditary Angioedema Drug Sales by Regions 2015-2020 (K Units) Table 10. Global Hereditary Angioedema Drug Sales Market Share by Regions (2015-2020) Table 11. Global Hereditary Angioedema Drug Revenue by Regions 2015-2020 (US$ Million) Table 12. Global Hereditary Angioedema Drug Sales by Manufacturers (2015-2020) (K Units) Table 13. Global Hereditary Angioedema Drug Sales Share by Manufacturers (2015-2020) Table 14. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 15. Global Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Drug as of 2019) Table 16. Hereditary Angioedema Drug Revenue by Manufacturers (2015-2020) (US$ Million) Table 17. Hereditary Angioedema Drug Revenue Share by Manufacturers (2015-2020) Table 18. Key Manufacturers Hereditary Angioedema Drug Price (2015-2020) (USD/Unit) Table 19. Hereditary Angioedema Drug Manufacturers Manufacturing Base Distribution and Headquarters Table 20. Manufacturers Hereditary Angioedema Drug Product Type Table 21. Date of International Manufacturers Enter into Hereditary Angioedema Drug Market Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans Table 23. Global Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 24. Global Hereditary Angioedema Drug Sales Share by Type (2015-2020) Table 25. Global Hereditary Angioedema Drug Revenue by Type (2015-2020) (US$ Million) Table 26. Global Hereditary Angioedema Drug Revenue Share by Type (2015-2020) Table 27. Hereditary Angioedema Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 28. Global Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 29. Global Hereditary Angioedema Drug Sales Share by Application (2015-2020) Table 30. North America Hereditary Angioedema Drug Sales by Country (2015-2020) (K Units) Table 31. North America Hereditary Angioedema Drug Sales Market Share by Country (2015-2020) Table 32. North America Hereditary Angioedema Drug Revenue by Country (2015-2020) (US$ Million) Table 33. North America Hereditary Angioedema Drug Revenue Market Share by Country (2015-2020) Table 34. North America Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 35. North America Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Table 36. North America Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 37. North America Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Table 38. Europe Hereditary Angioedema Drug Sales by Country (2015-2020) (K Units) Table 39. Europe Hereditary Angioedema Drug Sales Market Share by Country (2015-2020) Table 40. Europe Hereditary Angioedema Drug Revenue by Country (2015-2020) (US$ Million) Table 41. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2015-2020) Table 42. Europe Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 43. Europe Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Table 44. Europe Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 45. Europe Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Table 46. Asia Pacific Hereditary Angioedema Drug Sales by Region (2015-2020) (K Units) Table 47. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region (2015-2020) Table 48. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2015-2020) (US$ Million) Table 49. Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Region (2015-2020) Table 50. Asia Pacific Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 51. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Table 52. Asia Pacific Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 53. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Table 54. Latin America Hereditary Angioedema Drug Sales by Country (2015-2020) (K Units) Table 55. Latin America Hereditary Angioedema Drug Sales Market Share by Country (2015-2020) Table 56. Latin Americaa Hereditary Angioedema Drug Revenue by Country (2015-2020) (US$ Million) Table 57. Latin America Hereditary Angioedema Drug Revenue Market Share by Country (2015-2020) Table 58. Latin America Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 59. Latin America Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Table 60. Latin America Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 61. Latin America Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Table 62. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2015-2020) (K Units) Table 63. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Country (2015-2020) Table 64. Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2015-2020) (US$ Million) Table 65. Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Country (2015-2020) Table 66. Middle East and Africa Hereditary Angioedema Drug Sales by Type (2015-2020) (K Units) Table 67. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Table 68. Middle East and Africa Hereditary Angioedema Drug Sales by Application (2015-2020) (K Units) Table 69. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Table 70. Pharming Group NV Corporation Information Table 71. Pharming Group NV Description and Major Businesses Table 72. Pharming Group NV Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 73. Pharming Group NV Product Table 74. Pharming Group NV Recent Development Table 75. Takeda Corporation Information Table 76. Takeda Description and Major Businesses Table 77. Takeda Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Takeda Product Table 79. Takeda Recent Development Table 80. CSL Limited Corporation Information Table 81. CSL Limited Description and Major Businesses Table 82. CSL Limited Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. CSL Limited Product Table 84. CSL Limited Recent Development Table 85. IBio Inc. Corporation Information Table 86. IBio Inc. Description and Major Businesses Table 87. IBio Inc. Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. IBio Inc. Product Table 89. IBio Inc. Recent Development Table 90. BioCryst Pharmaceuticals, Inc. Corporation Information Table 91. BioCryst Pharmaceuticals, Inc. Description and Major Businesses Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. BioCryst Pharmaceuticals, Inc. Product Table 94. BioCryst Pharmaceuticals, Inc. Recent Development Table 95. Ionis Pharmaceuticals, Inc. Corporation Information Table 96. Ionis Pharmaceuticals, Inc. Description and Major Businesses Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Ionis Pharmaceuticals, Inc. Product Table 99. Ionis Pharmaceuticals, Inc. Recent Development Table 100. Global Hereditary Angioedema Drug Sales Forecast by Regions (2021-2026) (K Units) Table 101. Global Hereditary Angioedema Drug Sales Market Share Forecast by Regions (2021-2026) Table 102. Global Hereditary Angioedema Drug Revenue Forecast by Regions (2021-2026) (US$ Million) Table 103. Global Hereditary Angioedema Drug Revenue Market Share Forecast by Regions (2021-2026) Table 104. North America: Hereditary Angioedema Drug Sales Forecast by Country (2021-2026) (K Units) Table 105. North America: Hereditary Angioedema Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 106. Europe: Hereditary Angioedema Drug Sales Forecast by Country (2021-2026) (K Units) Table 107. Europe: Hereditary Angioedema Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 108. Asia Pacific: Hereditary Angioedema Drug Sales Forecast by Region (2021-2026) (K Units) Table 109. Asia Pacific: Hereditary Angioedema Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 110. Latin America: Hereditary Angioedema Drug Sales Forecast by Country (2021-2026) (K Units) Table 111. Latin America: Hereditary Angioedema Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 112. Middle East and Africa: Hereditary Angioedema Drug Sales Forecast by Country (2021-2026) (K Units) Table 113. Middle East and Africa: Hereditary Angioedema Drug Revenue Forecast by Country (2021-2026) (US$ Million) Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 115. Key Challenges Table 116. Market Risks Table 117. Main Points Interviewed from Key Hereditary Angioedema Drug Players Table 118. Hereditary Angioedema Drug Customers List Table 119. Hereditary Angioedema Drug Distributors List Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Hereditary Angioedema Drug Product Picture Figure 2. Global Hereditary Angioedema Drug Sales Market Share by Type in 2020 & 2026 Figure 3. C1 Esterase Inhibitor Product Picture Figure 4. Kallikrein Inhibitor Product Picture Figure 5. Selective Bradykinin B2 Receptor Antagonist Product Picture Figure 6. Global Hereditary Angioedema Drug Sales Market Share by Application in 2020 & 2026 Figure 7. Retail Pharmacies Figure 8. Hospital Pharmacies Figure 9. Online Pharmacies Figure 10. Hereditary Angioedema Drug Report Years Considered Figure 11. Global Hereditary Angioedema Drug Market Size 2015-2026 (US$ Million) Figure 12. Global Hereditary Angioedema Drug Sales 2015-2026 (K Units) Figure 13. Global Hereditary Angioedema Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Global Hereditary Angioedema Drug Sales Market Share by Region (2015-2020) Figure 15. Global Hereditary Angioedema Drug Sales Market Share by Region in 2019 Figure 16. Global Hereditary Angioedema Drug Revenue Market Share by Region (2015-2020) Figure 17. Global Hereditary Angioedema Drug Revenue Market Share by Region in 2019 Figure 18. Global Hereditary Angioedema Drug Sales Share by Manufacturer in 2019 Figure 19. The Top 10 and 5 Players Market Share by Hereditary Angioedema Drug Revenue in 2019 Figure 20. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Global Hereditary Angioedema Drug Sales Market Share by Type (2015-2020) Figure 22. Global Hereditary Angioedema Drug Sales Market Share by Type in 2019 Figure 23. Global Hereditary Angioedema Drug Revenue Market Share by Type (2015-2020) Figure 24. Global Hereditary Angioedema Drug Revenue Market Share by Type in 2019 Figure 25. Global Hereditary Angioedema Drug Market Share by Price Range (2015-2020) Figure 26. Global Hereditary Angioedema Drug Sales Market Share by Application (2015-2020) Figure 27. Global Hereditary Angioedema Drug Sales Market Share by Application in 2019 Figure 28. Global Hereditary Angioedema Drug Revenue Market Share by Application (2015-2020) Figure 29. Global Hereditary Angioedema Drug Revenue Market Share by Application in 2019 Figure 30. North America Hereditary Angioedema Drug Sales Growth Rate 2015-2020 (K Units) Figure 31. North America Hereditary Angioedema Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 32. North America Hereditary Angioedema Drug Sales Market Share by Country in 2019 Figure 33. North America Hereditary Angioedema Drug Revenue Market Share by Country in 2019 Figure 34. U.S. Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 35. U.S. Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Canada Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 37. Canada Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. North America Hereditary Angioedema Drug Market Share by Type in 2019 Figure 39. North America Hereditary Angioedema Drug Market Share by Application in 2019 Figure 40. Europe Hereditary Angioedema Drug Sales Growth Rate 2015-2020 (K Units) Figure 41. Europe Hereditary Angioedema Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 42. Europe Hereditary Angioedema Drug Sales Market Share by Country in 2019 Figure 43. Europe Hereditary Angioedema Drug Revenue Market Share by Country in 2019 Figure 44. Germany Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 45. Germany Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. France Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 47. France Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. U.K. Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 49. U.K. Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Italy Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 51. Italy Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Russia Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 53. Russia Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Europe Hereditary Angioedema Drug Market Share by Type in 2019 Figure 55. Europe Hereditary Angioedema Drug Market Share by Application in 2019 Figure 56. Asia Pacific Hereditary Angioedema Drug Sales Growth Rate 2015-2020 (K Units) Figure 57. Asia Pacific Hereditary Angioedema Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 58. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region in 2019 Figure 59. Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Region in 2019 Figure 60. China Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 61. China Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Japan Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 63. Japan Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. South Korea Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 65. South Korea Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. India Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 67. India Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Australia Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 69. Australia Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Taiwan Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 71. Taiwan Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Indonesia Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 73. Indonesia Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Thailand Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 75. Thailand Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Malaysia Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 77. Malaysia Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Philippines Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 79. Philippines Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Vietnam Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 81. Vietnam Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 82. Asia Pacific Hereditary Angioedema Drug Market Share by Type in 2019 Figure 83. Asia Pacific Hereditary Angioedema Drug Market Share by Application in 2019 Figure 84. Latin America Hereditary Angioedema Drug Sales Growth Rate 2015-2020 (K Units) Figure 85. Latin America Hereditary Angioedema Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 86. Latin America Hereditary Angioedema Drug Sales Market Share by Country in 2019 Figure 87. Latin America Hereditary Angioedema Drug Revenue Market Share by Country in 2019 Figure 88. Mexico Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 89. Mexico Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Brazil Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 91. Brazil Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Argentina Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 93. Argentina Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 94. Latin America Hereditary Angioedema Drug Market Share by Type in 2019 Figure 95. Latin America Hereditary Angioedema Drug Market Share by Application in 2019 Figure 96. Middle East and Africa Hereditary Angioedema Drug Sales Growth Rate 2015-2020 (K Units) Figure 97. Middle East and Africa Hereditary Angioedema Drug Revenue Growth Rate 2015-2020 (US$ Million) Figure 98. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Country in 2019 Figure 99. Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Country in 2019 Figure 100. Turkey Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 101. Turkey Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. Saudi Arabia Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 103. Saudi Arabia Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. U.A.E Hereditary Angioedema Drug Sales Growth Rate (2015-2020) (K Units) Figure 105. U.A.E Hereditary Angioedema Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 106. Middle East and Africa Hereditary Angioedema Drug Market Share by Type in 2019 Figure 107. Middle East and Africa Hereditary Angioedema Drug Market Share by Application in 2019 Figure 108. North America Hereditary Angioedema Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 109. North America Hereditary Angioedema Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 110. Europe Hereditary Angioedema Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 111. Europe Hereditary Angioedema Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Asia Pacific Hereditary Angioedema Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 113. Asia Pacific Hereditary Angioedema Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Latin America Hereditary Angioedema Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 115. Latin America Hereditary Angioedema Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Middle East and Africa Hereditary Angioedema Drug Sales Growth Rate Forecast (2021-2026) (K Units) Figure 117. Middle East and Africa Hereditary Angioedema Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 118. Porter's Five Forces Analysis Figure 119. Channels of Distribution Figure 120. Distributors Profiles Figure 121. Bottom-up and Top-down Approaches for This Report Figure 122. Data Triangulation Figure 123. Key Executives Interviewed

Pharming Group NV Takeda CSL Limited IBio Inc. BioCryst Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc.